HB 1338 (see companion bill SB 992) – Maryland
Status: Inactive / DeadYear Introduced: 2019
Link: http://mgaleg.maryland.gov/webmga/frmMain.aspx?id=hb1338&stab=01&pid=billpage&tab=subject3&ys=2019RS
equiring the Prescription Drug Monitoring Program to disclose prescription monitoring data, in accordance with certain regulations, to the medical director or authorized administrator of certain health care facilities, or the medical director’s or authorized administrator’s designee, for the purpose of providing medical or pharmaceutical treatment to a patient or prospective patient of the health care facility.
Key Issues:
PHARMACEUTICALS
PRICE AND QUALITY TRANSPARENCY
Return to Database Search
© 2018- The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.
Associated Litigation:
No items found